Usana Health Sciences

$81.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.85 (+4.96%) Today
+$0.05 (+0.06%) As of 8:38 AM EDT after-hours

Why Robinhood?

You can buy or sell USNA and other stocks, options, and ETFs commission-free!

About USNA

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, and Sense-beautiful science. Read More The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group. The Optimizers Nutritionals category consists of targeted supplements that support cardiovascular health, skeletal and structural health, and digestive health. The Foods Nutritionals category includes low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense-beautiful science includes premium, science-based, personal care products that support healthy skin and hair by providing topical nourishment, moisturization, and protection. The firm's brand include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT. The listed name for USNA is USANA Health Sciences Inc.

Employees
1,909
Headquarters
Salt Lake City, Utah
Founded
1992
Market Cap
1.71B
Price-Earnings Ratio
14.35
Dividend Yield
Average Volume
127.80K
High Today
$82.99
Low Today
$78.17
Open Price
$79.46
Volume
384.39K
52 Week High
$92.26
52 Week Low
$43.01

Collections

USNA News

BenzingaOct 19

Preview: Usana Health Sciences's Earnings

On Tuesday, October 20, Usana Health Sciences (NYSE: USNA) will release its latest earnings report. Check out Benzinga's preview to understand the implications.

USNA Earnings

$0.83
$1.03
$1.24
$1.44
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
$1.25 per share
Actual
$1.44 per share

You May Also Like